Last reviewed · How we verify
Very Low Dose Quillivant XR — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Very Low Dose Quillivant XR (Very Low Dose Quillivant XR) — Seattle Children's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Very Low Dose Quillivant XR TARGET | Very Low Dose Quillivant XR | Seattle Children's Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Very Low Dose Quillivant XR CI watch — RSS
- Very Low Dose Quillivant XR CI watch — Atom
- Very Low Dose Quillivant XR CI watch — JSON
- Very Low Dose Quillivant XR alone — RSS
Cite this brief
Drug Landscape (2026). Very Low Dose Quillivant XR — Competitive Intelligence Brief. https://druglandscape.com/ci/very-low-dose-quillivant-xr. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab